S&P 500   2,737.25 (+2.76%)
DOW   23,402.93 (+3.19%)
QQQ   200.81 (+2.20%)
AAPL   265.31 (+1.08%)
FB   171.34 (+3.50%)
MSFT   166.92 (+1.00%)
GOOGL   1,199.45 (+1.37%)
AMZN   2,025.10 (+1.38%)
CGC   14.78 (+3.07%)
NVDA   268.32 (-0.03%)
BABA   200.33 (+1.98%)
MU   47.83 (+3.15%)
TSLA   555.47 (+7.60%)
AMD   48.77 (+2.61%)
T   30.61 (+3.94%)
ACB   0.81 (+1.24%)
F   4.93 (+8.60%)
NFLX   379.63 (-0.09%)
BAC   22.64 (+5.85%)
GILD   75.07 (-3.43%)
DIS   104.09 (+4.53%)
S&P 500   2,737.25 (+2.76%)
DOW   23,402.93 (+3.19%)
QQQ   200.81 (+2.20%)
AAPL   265.31 (+1.08%)
FB   171.34 (+3.50%)
MSFT   166.92 (+1.00%)
GOOGL   1,199.45 (+1.37%)
AMZN   2,025.10 (+1.38%)
CGC   14.78 (+3.07%)
NVDA   268.32 (-0.03%)
BABA   200.33 (+1.98%)
MU   47.83 (+3.15%)
TSLA   555.47 (+7.60%)
AMD   48.77 (+2.61%)
T   30.61 (+3.94%)
ACB   0.81 (+1.24%)
F   4.93 (+8.60%)
NFLX   379.63 (-0.09%)
BAC   22.64 (+5.85%)
GILD   75.07 (-3.43%)
DIS   104.09 (+4.53%)
S&P 500   2,737.25 (+2.76%)
DOW   23,402.93 (+3.19%)
QQQ   200.81 (+2.20%)
AAPL   265.31 (+1.08%)
FB   171.34 (+3.50%)
MSFT   166.92 (+1.00%)
GOOGL   1,199.45 (+1.37%)
AMZN   2,025.10 (+1.38%)
CGC   14.78 (+3.07%)
NVDA   268.32 (-0.03%)
BABA   200.33 (+1.98%)
MU   47.83 (+3.15%)
TSLA   555.47 (+7.60%)
AMD   48.77 (+2.61%)
T   30.61 (+3.94%)
ACB   0.81 (+1.24%)
F   4.93 (+8.60%)
NFLX   379.63 (-0.09%)
BAC   22.64 (+5.85%)
GILD   75.07 (-3.43%)
DIS   104.09 (+4.53%)
S&P 500   2,737.25 (+2.76%)
DOW   23,402.93 (+3.19%)
QQQ   200.81 (+2.20%)
AAPL   265.31 (+1.08%)
FB   171.34 (+3.50%)
MSFT   166.92 (+1.00%)
GOOGL   1,199.45 (+1.37%)
AMZN   2,025.10 (+1.38%)
CGC   14.78 (+3.07%)
NVDA   268.32 (-0.03%)
BABA   200.33 (+1.98%)
MU   47.83 (+3.15%)
TSLA   555.47 (+7.60%)
AMD   48.77 (+2.61%)
T   30.61 (+3.94%)
ACB   0.81 (+1.24%)
F   4.93 (+8.60%)
NFLX   379.63 (-0.09%)
BAC   22.64 (+5.85%)
GILD   75.07 (-3.43%)
DIS   104.09 (+4.53%)
Log in

NASDAQ:CRISCuris News Headlines

$0.65
+0.01 (+1.56 %)
(As of 04/7/2020 12:54 PM ET)
Add
Compare
Today's Range
$0.65
Now: $0.65
$0.67
50-Day Range
$0.66
MA: $1.03
$1.46
52-Week Range
$0.65
Now: $0.65
$2.90
Volume1,100 shs
Average Volume198,937 shs
Market Capitalization$23.78 million
P/E RatioN/A
Dividend YieldN/A
Beta2.35

Headlines

Curis (NASDAQ CRIS) News Headlines

Source:
DateHeadline
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Yahoo FinanceCuris Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Yahoo Finance
finance.yahoo.com - April 3 at 5:10 PM
Curis, Inc. (NASDAQ:CRIS) Sees Large Decline in Short InterestCuris, Inc. (NASDAQ:CRIS) Sees Large Decline in Short Interest
www.americanbankingnews.com - March 28 at 5:00 PM
Edited Transcript of CRIS earnings conference call or presentation 19-Mar-20 8:30pm GMT - Yahoo FinanceEdited Transcript of CRIS earnings conference call or presentation 19-Mar-20 8:30pm GMT - Yahoo Finance
finance.yahoo.com - March 26 at 9:14 PM
Edited Transcript of CRIS earnings conference call or presentation 19-Mar-20 8:30pm GMTEdited Transcript of CRIS earnings conference call or presentation 19-Mar-20 8:30pm GMT
finance.yahoo.com - March 26 at 9:14 PM
Global Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Pipeline Guide, 2020 - Therapeutics, Drugs, Players, and Developments - Yahoo FinanceGlobal Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Pipeline Guide, 2020 - Therapeutics, Drugs, Players, and Developments - Yahoo Finance
finance.yahoo.com - March 25 at 6:33 PM
Curis Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Business Update - Yahoo FinanceCuris Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Business Update - Yahoo Finance
finance.yahoo.com - March 21 at 5:28 PM
Curis (NASDAQ:CRIS) Releases Quarterly  Earnings Results, Misses Expectations By $0.06 EPSCuris (NASDAQ:CRIS) Releases Quarterly Earnings Results, Misses Expectations By $0.06 EPS
www.americanbankingnews.com - March 20 at 9:41 AM
BRIEF-Curis Reports Fourth Quarter And Year-End 2019 Financial Results And Provides Business Update - ReutersBRIEF-Curis Reports Fourth Quarter And Year-End 2019 Financial Results And Provides Business Update - Reuters
www.reuters.com - March 19 at 10:33 PM
Curis, Inc. to Host Earnings Call - Yahoo FinanceCuris, Inc. to Host Earnings Call - Yahoo Finance
finance.yahoo.com - March 19 at 10:33 PM
EARNINGS SUMMARY: Details of Curis Inc Q4 Earnings ReportEARNINGS SUMMARY: Details of Curis Inc Q4 Earnings Report
www.nasdaq.com - March 19 at 5:33 PM
Curis, Inc. to Host Earnings CallCuris, Inc. to Host Earnings Call
finance.yahoo.com - March 19 at 5:33 PM
Curis Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Business UpdateCuris Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Business Update
finance.yahoo.com - March 19 at 5:33 PM
Curis, Inc. (CRIS)Curis, Inc. (CRIS)
finance.yahoo.com - March 19 at 7:32 AM
Curis (CRIS) Set to Announce Quarterly Earnings on ThursdayCuris (CRIS) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - March 13 at 9:49 AM
Curis to Release Fourth Quarter and Year-End 2019 Financial Results and Hold Conference Call on March 19, 2020 - Yahoo FinanceCuris to Release Fourth Quarter and Year-End 2019 Financial Results and Hold Conference Call on March 19, 2020 - Yahoo Finance
finance.yahoo.com - March 12 at 5:52 PM
Curis to Release Fourth Quarter and Year-End 2019 Financial Results and Hold Conference Call on March 19, 2020Curis to Release Fourth Quarter and Year-End 2019 Financial Results and Hold Conference Call on March 19, 2020
finance.yahoo.com - March 12 at 12:51 PM
Layer 3 Platform FinNexus Will Hold World’s First ICTO on Bitrue Exchange - Yahoo FinanceLayer 3 Platform FinNexus Will Hold World’s First ICTO on Bitrue Exchange - Yahoo Finance
finance.yahoo.com - March 4 at 8:06 AM
Curis Announces $30 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC - Yahoo FinanceCuris Announces $30 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC - Yahoo Finance
finance.yahoo.com - February 27 at 12:16 PM
Curis Announces $30 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLCCuris Announces $30 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
finance.yahoo.com - February 27 at 12:16 PM
Healthfully Releases New Version of Integrated Consumer Health Platform - Yahoo FinanceHealthfully Releases New Version of Integrated Consumer Health Platform - Yahoo Finance
finance.yahoo.com - February 27 at 7:16 AM
Healthfully Releases New Version of Integrated Consumer Health Platform - PRNewswireHealthfully Releases New Version of Integrated Consumer Health Platform - PRNewswire
www.prnewswire.com - February 26 at 3:00 PM
Optima Curis Rebrands to Healthfully - BenzingaOptima Curis Rebrands to Healthfully - Benzinga
www.benzinga.com - February 21 at 9:08 AM
Optima Curis Rebrands to Healthfully - Yahoo FinanceOptima Curis Rebrands to Healthfully - Yahoo Finance
finance.yahoo.com - February 20 at 5:45 PM
Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170 - Yahoo FinanceCuris and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170 - Yahoo Finance
finance.yahoo.com - February 6 at 2:47 PM
Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170 - PRNewswireCuris and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170 - PRNewswire
www.prnewswire.com - February 6 at 9:46 AM
Curis® and DarwinHealth Announce Scientific Collaboration to Characterize Biomarkers and Tumor Subtype Alignments for Fimepinostat in DLBCL and Solid Malignancies - Yahoo FinanceCuris® and DarwinHealth Announce Scientific Collaboration to Characterize Biomarkers and Tumor Subtype Alignments for Fimepinostat in DLBCL and Solid Malignancies - Yahoo Finance
finance.yahoo.com - January 13 at 8:58 PM
Curis® and DarwinHealth Announce Scientific Collaboration to Characterize Biomarkers and Tumor Subtype Alignments for Fimepinostat in DLBCL and Solid MalignanciesCuris® and DarwinHealth Announce Scientific Collaboration to Characterize Biomarkers and Tumor Subtype Alignments for Fimepinostat in DLBCL and Solid Malignancies
finance.yahoo.com - January 13 at 3:57 PM
Curis up 9% premarket on deal with ImmuNext in cancer - Seeking AlphaCuris up 9% premarket on deal with ImmuNext in cancer - Seeking Alpha
seekingalpha.com - January 9 at 4:02 AM
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
finance.yahoo.com - January 8 at 4:33 PM
Curis Announces Option and License Agreement with ImmuNext for the Development and Commercialization of Anti-VISTA Antibodies - PRNewswireCuris Announces Option and License Agreement with ImmuNext for the Development and Commercialization of Anti-VISTA Antibodies - PRNewswire
www.prnewswire.com - January 7 at 10:19 AM
Curis Announces Option and License Agreement with ImmuNext for the Development and Commercialization of Anti-VISTA AntibodiesCuris Announces Option and License Agreement with ImmuNext for the Development and Commercialization of Anti-VISTA Antibodies
finance.yahoo.com - January 7 at 10:18 AM
Curis up 9% premarket on deal with ImmuNext in cancerCuris up 9% premarket on deal with ImmuNext in cancer
seekingalpha.com - January 7 at 9:08 AM
Jamie Lee Curis and Lin Shaye in The Grudge are redefining, and empowering, scream queens - NBCNews.comJamie Lee Curis and Lin Shaye in 'The Grudge' are redefining, and empowering, scream queens - NBCNews.com
www.nbcnews.com - January 4 at 6:30 AM
Should You Buy Curis, Inc. (CRIS)? - Yahoo FinanceShould You Buy Curis, Inc. (CRIS)? - Yahoo Finance
finance.yahoo.com - December 23 at 7:23 PM
The Curis (NASDAQ:CRIS) Share Price Is Up 103% And Shareholders Are Boasting About It - Yahoo FinanceThe Curis (NASDAQ:CRIS) Share Price Is Up 103% And Shareholders Are Boasting About It - Yahoo Finance
finance.yahoo.com - December 22 at 12:14 PM
The Curis (NASDAQ:CRIS) Share Price Is Up 103% And Shareholders Are Boasting About ItThe Curis (NASDAQ:CRIS) Share Price Is Up 103% And Shareholders Are Boasting About It
finance.yahoo.com - December 22 at 12:14 PM
Clovis Oncology among healthcare gainers; Curis among losers - Seeking AlphaClovis Oncology among healthcare gainers; Curis among losers - Seeking Alpha
seekingalpha.com - December 6 at 2:55 PM
Curis Provides First-Ever Demonstration that Targeting IRAK4 in Patients with Relapsed/Refractory Non-Hodgkins Lymphoma Results in Anti-Cancer Activity in Ongoing Phase 1 Study - PRNewswireCuris Provides First-Ever Demonstration that Targeting IRAK4 in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma Results in Anti-Cancer Activity in Ongoing Phase 1 Study - PRNewswire
www.prnewswire.com - December 6 at 2:55 PM
Curis Provides First-Ever Demonstration that Targeting IRAK4 in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma Results in Anti-Cancer Activity in Ongoing Phase 1 StudyCuris Provides First-Ever Demonstration that Targeting IRAK4 in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma Results in Anti-Cancer Activity in Ongoing Phase 1 Study
finance.yahoo.com - December 6 at 9:54 AM
Curis To Present At Piper Jaffray Conference; Webcast At 11:30 AM ET - NasdaqCuris To Present At Piper Jaffray Conference; Webcast At 11:30 AM ET - Nasdaq
www.nasdaq.com - December 3 at 1:14 PM
Edited Transcript of CRIS earnings conference call or presentation 5-Nov-19 1:30pm GMT - Yahoo FinanceEdited Transcript of CRIS earnings conference call or presentation 5-Nov-19 1:30pm GMT - Yahoo Finance
finance.yahoo.com - November 20 at 6:08 PM
Edited Transcript of CRIS earnings conference call or presentation 5-Nov-19 1:30pm GMTEdited Transcript of CRIS earnings conference call or presentation 5-Nov-19 1:30pm GMT
finance.yahoo.com - November 20 at 6:08 PM
Curis Abstracts for Fimepinostat and CA-4948 Accepted for Presentation at the 61st Annual Meeting of the American Society of Hematology - Yahoo FinanceCuris Abstracts for Fimepinostat and CA-4948 Accepted for Presentation at the 61st Annual Meeting of the American Society of Hematology - Yahoo Finance
finance.yahoo.com - November 8 at 8:46 AM
Curis Abstracts for Fimepinostat and CA-4948 Accepted for Presentation at the 61st Annual Meeting of the American Society of Hematology - PRNewswireCuris Abstracts for Fimepinostat and CA-4948 Accepted for Presentation at the 61st Annual Meeting of the American Society of Hematology - PRNewswire
www.prnewswire.com - November 6 at 2:00 PM
Curis Abstracts for Fimepinostat and CA-4948 Accepted for Presentation at the 61st Annual Meeting of the American Society of HematologyCuris Abstracts for Fimepinostat and CA-4948 Accepted for Presentation at the 61st Annual Meeting of the American Society of Hematology
finance.yahoo.com - November 6 at 2:00 PM
Curis Inc.s (CRIS) CEO James Dentzer on Q3 2019 Results - Earnings Call Transcript - Seeking AlphaCuris Inc.'s (CRIS) CEO James Dentzer on Q3 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 5 at 11:11 PM
ImmunoGen among healthcare gainers; Curis and CHF Solutions among losers - Seeking AlphaImmunoGen among healthcare gainers; Curis and CHF Solutions among losers - Seeking Alpha
seekingalpha.com - November 5 at 1:10 PM
Curis Reports Third Quarter 2019 Financial Results - PRNewswireCuris Reports Third Quarter 2019 Financial Results - PRNewswire
www.prnewswire.com - November 5 at 8:09 AM
Curis Reports Third Quarter 2019 Financial ResultsCuris Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 5 at 8:09 AM
/U P D A T E D -- Curis, Inc./ - Yahoo Finance/U P D A T E D -- Curis, Inc./ - Yahoo Finance
finance.yahoo.com - October 31 at 11:50 PM
This page was last updated on 4/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel